Mild behavioral impairment: Ethical, methodological and clinical reflections

Area of Science:

• Neuroscience
• Gerontology
• Psychiatry

Background:

• Mild behavioral impairment (MBI) is a novel construct proposed to capture neuropsychiatric symptoms (NPS) not meeting criteria for major psychiatric disorders.
• These NPS may represent early indicators of underlying neurodegenerative processes, potentially preceding the clinical manifestation of dementia.
• The concept of MBI is of significant interest for early detection and intervention in neurodegenerative diseases.

Purpose of the Study:

• To critically evaluate the definition and operationalization of mild behavioral impairment (MBI).
• To discuss the potential of MBI as a pre-dementia phenotype.
• To highlight areas requiring careful consideration in the conceptualization of MBI.

Main Methods:

• This is a commentary discussing existing literature and concepts.
• Analysis of the rationale and implications of the MBI construct.
• Identification of key issues and considerations for defining MBI.

Main Results:

• The construct of MBI is recently introduced and requires further refinement.
• MBI holds promise as an early marker for neurodegenerative diseases.
• Several conceptual and operational challenges need to be addressed for MBI.

Conclusions:

• The concept of MBI warrants attention as a potential indicator of preclinical neurodegeneration.
• Further research and consensus are needed to refine the definition and application of MBI.
• Understanding MBI is crucial for identifying individuals at risk for dementia and implementing timely interventions.